CytomX Therapeutics, Inc. (CTMX)
 NASDAQ: CTMX · Real-Time Price · USD
 3.930
 +0.360 (10.08%)
  At close: Nov 3, 2025, 4:00 PM EST
4.080
 +0.150 (3.82%)
  After-hours: Nov 3, 2025, 7:49 PM EST
CytomX Therapeutics Employees
As of December 31, 2024, CytomX Therapeutics had 121 total employees, including 119 full-time and 2 part-time employees. The number of employees decreased by 1 or -0.82% compared to the previous year.
Employees 
 121
Change (1Y) 
 -1
Growth (1Y) 
 -0.82%
Revenue / Employee 
 $1,166,116
Profits / Employee 
 $396,554
Market Cap 
648.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 121 | -1 | -0.82% | 
| Dec 31, 2023 | 122 | 4 | 3.39% | 
| Dec 31, 2022 | 118 | -60 | -33.71% | 
| Dec 31, 2021 | 178 | 32 | 21.92% | 
| Dec 31, 2020 | 146 | -14 | -8.75% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
CTMX News
- 4 days ago - CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
 - 14 days ago - CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer - GlobeNewsWire
 - 21 days ago - CytomX Therapeutics: Additional Run Up Into The Q1 2026 Readout Is Possible - Seeking Alpha
 - 22 days ago - Renewed Tariff Fears Spotlight Top Performing Stocks Since April - Seeking Alpha
 - 4 weeks ago - CytomX: A Fresh Start With New Drugs After Total Pipeline Failure - Seeking Alpha
 - 7 weeks ago - CytomX Therapeutics, Inc. (CTMX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
 - 2 months ago - CytomX Therapeutics to Present at Upcoming September Investor Conferences - GlobeNewsWire
 - 2 months ago - CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study - GlobeNewsWire